RGRX
RegeneRx Biopharmaceuticals, Inc.
OTCHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
J. J. Finkelstein
IPO Date
2003-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
RegeneRx Biopharmaceuticals, Inc.
CEO
J. J. Finkelstein
IPO Date
2003-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 0 |
| $0.00 |
| 19 May 2022 | Noseda Alessandro | director: | A-Award | Acquired | 240,000 | $0.00 |
| 19 May 2022 | Noseda Alessandro | director | A-Award | Acquired | 240,000 | $0.19 |
| 19 May 2022 | GOLDSTEIN ALLAN L | director: | A-Award | Acquired | 480,000 | $0.00 |
| 19 May 2022 | GOLDSTEIN ALLAN L | director | A-Award | Acquired | 480,000 | $0.19 |
| 19 May 2022 | FINKELSTEIN J J | President and CEO | A-Award | Acquired | 600,000 | $0.00 |
| 19 May 2022 | MCNAY JOSEPH C | director: | A-Award | Acquired | 290,000 | $0.00 |
| 19 May 2022 | MCNAY JOSEPH C | director | A-Award | Acquired | 290,000 | $0.19 |
| 19 May 2022 | Elsey R Don | director: | A-Award | Acquired | 290,000 | $0.00 |